Red Apple Dental, P.c. in Montgomery, NY - Dentist

Red Apple Dental, P.c. is a dental clinic (Dentist - General Practice) in Montgomery, New York. The current practice location for Red Apple Dental, P.c. is 2711 Albany Post Rd, Montgomery, New York. For appointments, you can reach them via phone at (845) 457-1647. The mailing address for Red Apple Dental, P.c. is 2711 Albany Post Rd, Montgomery, New York and phone number is (845) 457-1647.

Red Apple Dental, P.c. is licensed to practice in New York (license number 043245) and its NPI number is 1437209152. This medical practice does not participate in medicare program and thus may not accept your medicare insurance. You may check if they accept your insurance at (845) 457-1647.

Contact Information

	Red Apple Dental, P.c.
	2711 Albany Post Rd Montgomery NY 12549-2158
	(845) 457-1647
	(845) 818-3921

Dental Care Clinic Profile

Full Name	Red Apple Dental, P.c.
Speciality	Dentist - General Practice
Location	2711 Albany Post Rd, Montgomery, New York
Authorized Official Name and Position	Gregory T Mcmahon (DENTIST)
Authorized Official Contact	8454571647
Accepts Medicare Insurance	This clinic does not participate in Medicare Program.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Red Apple Dental, P.c. 2711 Albany Post Rd Montgomery NY 12549-2158 Ph: (845) 457-1647	Red Apple Dental, P.c. 2711 Albany Post Rd Montgomery NY 12549-2158 Ph: (845) 457-1647

NPI Details:

NPI Number	1437209152
Provider Enumeration Date	01/12/2007
Last Update Date	08/22/2020

Medical Identifiers

Medical identifiers for Red Apple Dental, P.c. such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1437209152	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
1223G0001X	Dentist - General Practice	043245 (New York)	Primary

News Archive

LEAPS vaccine technology generates dendritic cells to stimulate immune system to fight viral illnesses

CEL-SCI Corporation and researchers at the Northeastern Ohio Universities Colleges of Medicine and Pharmacy (NEOUCOM) jointly announced today that a LEAPS-based vaccine (Ligand Epitope Antigen Presentation System) study has demonstrated the technology's potential using dendritic cells to stimulate the immune system to fight viral illnesses and other diseases.

Medicago announces official groundbreaking ceremony for U.S. plant-based commercial grade vaccine facility

Medicago U.S.A. Inc., a wholly owned subsidiary of Medicago Inc., a biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced that company executives, along with U.S. Senator Kay Hagan (D-NC) and U.S. Congressman David Price (D-NC), are holding an official groundbreaking ceremony this morning for its U.S. plant-based commercial grade vaccine facility in Research Triangle Park, North Carolina.

Cognizant announces acquisition of Cadient Group

Cognizant today announced it has acquired Cadient Group, a full-service digital marketing agency that serves a broad spectrum of life sciences companies in the pharmaceutical, biotechnology, consumer health, and medical device industries.

Immunomedics reports CD22 antibody produced significant anti-tumor response

Immunomedics, a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today reported that epratuzumab, the Company's humanized anti-CD22 antibody, conjugated with SN-38, the active component of irinotecan, produced significant anti-tumor responses in a mouse model of human lymphoma.

Red Apple Dental, P.c. - Dental Clinic in Montgomery, NY